OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic blockade of ER stress and inflammation prevents NASH and progression to HCC
Ebru Boslem, Saskia Reibe, Rodrigo Carlessi, et al.
Science Advances (2023) Vol. 9, Iss. 37
Open Access | Times Cited: 19

Showing 19 citing articles:

MASLD: a systemic metabolic disorder with cardiovascular and malignant complications
Giovanni Targher, Christopher D. Byrne, Herbert Tilg
Gut (2024), pp. gutjnl-330595
Open Access | Times Cited: 242

The double-edged effects of IL-6 in liver regeneration, aging, inflammation, and diseases
Minjun Wang, Hailing Zhang, Fei Chen, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 11

Oligonucleotide therapies for nonalcoholic steatohepatitis
Sixu Li, Feng Xiong, Songbo Zhang, et al.
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 2, pp. 102184-102184
Open Access | Times Cited: 9

Macrophages and T cells in metabolic disorder-associated cancers
Daniel Taranto, Daan J. Kloosterman, Leila Akkari
Nature reviews. Cancer (2024)
Closed Access | Times Cited: 9

Dendritic cell maturation in cancer
Chang Moon, Meriem Belabed, Matthew D. Park, et al.
Nature reviews. Cancer (2025)
Closed Access | Times Cited: 1

Exogenous hydrogen sulfide improves non-alcoholic fatty liver disease by inhibiting endoplasmic reticulum stress/NLRP3 inflammasome pathway
Xiaodi Fu, Qi Zhang, Yuhang Chen, et al.
Molecular and Cellular Biochemistry (2025)
Closed Access | Times Cited: 1

The effect of ertugliflozin in patients with nonalcoholic fatty liver disease associated with type 2 diabetes mellitus: A randomized controlled trial
Adil Khaliq, Haroon Badshah, Yasar Shah, et al.
Medicine (2024) Vol. 103, Iss. 45, pp. e40356-e40356
Open Access | Times Cited: 5

Inhibition of IRE‐1α Alleviates Pyroptosis and Metabolic Dysfunction‐Associated Steatohepatitis by Suppressing Gasdermin D
Xin Zeng, Tian Wu, Qing Xu, et al.
Liver International (2025) Vol. 45, Iss. 2
Closed Access

Ursolic acid suppresses fatty liver-associated hepatocellular carcinoma by regulating lipid metabolism
Mingyan Dong, Qi Cui, Yunong Li, et al.
Food Bioscience (2024) Vol. 60, pp. 104460-104460
Open Access | Times Cited: 3

Derlin-1 promotes diet-induced non-alcoholic fatty liver disease via increasing RIPK3-mediated necroptosis
Ting Wang, Dehua Wang, Ge Kuang, et al.
Free Radical Biology and Medicine (2024) Vol. 217, pp. 29-47
Closed Access | Times Cited: 2

Endoplasmic Reticulum Stress Signaling in the Regulation of Hepatic Pathological Responses
Ananda Baral
Stresses (2024) Vol. 4, Iss. 3, pp. 481-504
Open Access | Times Cited: 1

Direct degradation and stabilization of proteins: New horizons in treatment of nonalcoholic steatohepatitis
Yibing Wang, Jianan Zheng, Yun‐Ze Long, et al.
Biochemical Pharmacology (2023) Vol. 220, pp. 115989-115989
Closed Access | Times Cited: 2

The Biology of Interleukin-6: A Major Target in Anti-Inflammatory Therapies
Stefan Rose‐John
Elsevier eBooks (2024)
Closed Access

Role of AMPK
Sihai Dave Zhao, Weilun Fang, Wei Yu, et al.
PubMed (2024) Vol. 49, Iss. 12, pp. 1891-1901
Closed Access

Page 1

Scroll to top